Prostate-cancer-associated-fibroblast–derived exosomes carrying miR-423-5p are reported to increase taxane resistance in prostate cancer through the TGF-β signaling pathway by targeting GREM2 (144). The gene discussed is GREM2; the disease is prostate carcinoma.